Implementing CRM Learnings and Utilization of Telehealth

Key Takeaways

Collaboration among stakeholders is essential for improving CRM care and aligning initiatives with shared goals.
Value-based care models incentivize healthcare providers to focus on patient outcomes, enhancing care quality for CRM conditions.
Financial support from pharmaceutical companies can drive research, education, and technology integration in CRM care.
Effective communication and data sharing are critical for measuring success and optimizing resource utilization in CRM care.

The panel of experts concludes by exploring the implementation of cardiometabolic risk management learnings and the utilization of telehealth in clinical practice.

EP: 1.The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity

EP: 2.Strategies for Prevention and Screening of CRM Conditions

EP: 3.The Link Between Obesity and CRM Conditions

EP: 4.Challenges in Managing Co-Morbid CRM Conditions

EP: 5.Contemporary Guidelines for CRM Conditions

EP: 6.Reasons for Low Adherence to Guidelines for CRM Conditions

EP: 7.Overcoming Barriers to Prescribing First-Line Medications for CRM Conditions

EP: 8.Educational Initiatives to Enhance Guideline Adherence in CRM

EP: 9.Addressing Gaps in CKD, T2D, and CVD Guidelines

EP: 10.Care Coordination for High-Risk CRM Patients

EP: 11.Takeaways from the UH CINEMA Program

EP: 12.Exploring the Kidney-CHAMP Study

EP: 13.Insights from the COORDINATE-Diabetes Trial

EP: 14.Coordinating Initiatives to Enhance CRM Care

Now Viewing

EP: 15.Implementing CRM Learnings and Utilization of Telehealth

Video content above is prompted by the following:

How can learnings from programs and studies, like those discussed today, be disseminated, scaled, and implemented at health systems across the US?
With the rise of telehealth, healthcare has never been as accessible as it is now. What are some of the creative ways you and your healthcare organization have implemented technology to better patient care coordination? (Dr. Jhamb)
How have you gained organization support for improved care coordination?
What new challenges have risen because of innovative technologies?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.